MedTrace Logo

Robotic Assisted Transanal Total Mesorectal Excision Surgery for Rectal Cancer in Low Site

NCT03422835 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2018-02-06

No results posted yet for this study

Summary

To investigates the feasibility, practicability, safety and subjective as well as functional outcome of Robotic transanal total mesentery excision for rectal cancer in low site.

Conditions

  • Rectal Neoplasms

Interventions

PROCEDURE

R-TME

Conventional Robotic Total Mesentery Excision

PROCEDURE

R-TaTME

Robotic Transanal Total Mesentery Excision

Sponsors & Collaborators

  • Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

    lead OTHER

Principal Investigators

  • fan li, MD. · Daping Hospital, Third Military Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-15
Primary Completion
2020-12-30
Completion
2023-12-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03422835 on ClinicalTrials.gov